Product Details

Veroquin Syrup delivers Chloroquine Phosphate for the treatment and prevention of malaria in children and patients who cannot swallow tablets. Specifically, each 5ml contains Chloroquine Phosphate IP equivalent to 50mg Chloroquine, in a flavoured syrup base. As a result, it offers an accurately dosed antimalarial treatment option in a convenient liquid formulation.

The syrup contains:

• Chloroquine Phosphate IP (equivalent to Chloroquine 50mg per 5ml, in a flavoured syrup base) – A 4-aminoquinoline antimalarial that accumulates within the parasite’s digestive vacuole and interferes with haem detoxification. Consequently, it disrupts the malaria parasite’s survival mechanisms, clearing susceptible Plasmodium species from the bloodstream.

Physicians prescribe Veroquin for the treatment of malaria caused by susceptible Plasmodium species, as well as for malaria chemoprophylaxis in appropriate clinical circumstances. In addition, its oral syrup format, together with the calibrated dosing cap, supports accurate weight-based dosing in children. Because of this profile, Veroquin suits paediatric practices, general practice, and public health settings managing malaria treatment and prevention, always under the guidance of a physician.

Key Features:

• Overall, this formulation guarantees pharmaceutical-grade purity
• Additionally, the flavoured syrup base and calibrated dosing cap support accurate paediatric dosing
• Furthermore, each 5ml delivers precise, validated dosage accuracy at 50mg
• Notably, rigorous quality testing backs every stage of manufacturing
• Beyond that, amber bottle packaging protects the light-sensitive formulation
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and public health programs